Non-Pharmacological Treatment of Vestibular Migraine in Children and Adolescent
Effects of Lifestyle Modifications and Vestibular Rehabilitation Therapy in Children and Adolescents With Vestibular Migraine
1 other identifier
interventional
30
1 country
1
Brief Summary
Vestibular dysfunction has traditionally been linked to various conditions that affect older adults. Recent studies have shown that children and adolescents suffer from vestibular impairments, yet the numbers are still low due to some factors, including the non-typical presentations. Vestibular migraine has been found to be the most common condition of vestibular dysfunction among children and adolescents. Nonetheless, most children remain undiagnosed due to lack awareness and vague clinical presentations. Parallel to that, there has been no consensus regarding the management algorithm. Most children are managed with pharmacological management extrapolated from the adult algorithm. Many clinicians fail to understand that pharmacological treatments are not sustainable long-term and should focus on lifestyle modifications such as sleep and dietary habits and other non-pharmacological treatments such as deep breathing exercises and vestibular rehabilitation therapy. This study aims to investigate the effect of non-pharmacological treatment in managing children and adolescents with VM. The investigators will use a standardised questionnaire before and after interventions to investigate the effect of lifestyle modifications, simple vestibular rehabilitation exercises and deep breathing techniques in children and adolescents with VM. Lifestyle modifications and vestibular rehabilitation exercise is a more sustainable way of managing children and adolescents with VM, avoiding the side effects of medication, and is more cost-effective. If the non-pharmacological treatment shows promising results, the investigators will continue with multicentre randomised-controlled studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedJune 22, 2023
June 1, 2023
1 year
May 8, 2023
June 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Paediatric Dizziness Handicap Inventory
This measure assesses impact of dizziness in children between 5-12 years
This measure is carried after one month
Dizziness Handicap Inventory
This measure assesses impact of dizziness in children above 12 -18
This measure is carried out after one month
Study Arms (1)
Vestibular Migraine group
EXPERIMENTALWritten, verbal and pictorial descriptions will be provided for each participant regarding lifestyle modifications and vestibular rehabilitation exercise
Interventions
Written suggestions on lifestyle modifications including duration of sleep, meal frequency, reduce screen time, exercise duration, food to avoid.
Each participant will be taught simple home-based vestibular rehabilitation exercise, which needs to be repeated
Eligibility Criteria
You may qualify if:
- Children and adolescents between 5-18 years
- Diagnosed with vestibular migraine based on the Diagnostic criteria consensus document of the Classification Committee of Vestibular Disorders of the Bárány Society and the International Headache Society
You may not qualify if:
- Not able to comprehend or able to follow instructions
- syndromic, other ontological, neurological conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universiti Malaya Medical Centre
Kuala Lumpur, 500603, Malaysia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 8, 2023
First Posted
June 22, 2023
Study Start
November 1, 2023
Primary Completion
November 1, 2024
Study Completion
December 1, 2024
Last Updated
June 22, 2023
Record last verified: 2023-06